Story
Tel Aviv 35 Index Gains 1.22% on Strength in Financials

Summary
Israel's benchmark TA 35 stock index closed higher on Thursday, buoyed by strong performance in the banking and financial sectors, with Tower Semiconductor leading individual gains.
Israel's benchmark stock index, the TA 35, closed 1.22% higher on Thursday, propelled by a rally in the nation's banking, financials, and insurance sectors. The positive close came despite a mixed performance among individual large-cap stocks.
Session Highlights
Thursday's trading session on the Tel Aviv Stock Exchange saw a narrow division between advancing and declining stocks. According to closing data, 229 companies saw their shares rise, while 219 fell and 110 remained unchanged, indicating that the index's gains were concentrated in specific heavyweight sectors rather than a broad-based market rally.
Key movers on the TA 35 index included a mix of technology and energy companies. The top performers were:
- Tower Semiconductor Ltd (TASE:TSEM), which surged 5.02%.
- Enlight Renewable Energy Ltd (TASE:ENLT), which added 4.48%.
- Camtek Ltd (TASE:CAMT), closing up 3.62%.
AdConversely, software company NICE Ltd (TASE:NICE) was the session's most significant laggard, with its shares falling 8.20%. Other notable decliners included retailer Shufersal (TASE:SAE), down 3.53%, and the Tel Aviv Stock Exchange (TASE:TASE) itself, which saw its own stock decline 3.35%.
Broader Market Context
In the foreign exchange market, the Israeli shekel strengthened against the U.S. dollar, with the USD/ILS pair declining 0.32% to 3.07. Meanwhile, global commodity markets presented a mixed picture, with gold futures rising 1.53% while Brent crude oil futures fell 1.04%.
Read next
More on Stocks
ClearPoint Neuro Stock Plummets 24% on uniQure's Huntington's Trial Setback
Shares of ClearPoint Neuro fell sharply after its partner, uniQure, announced that its experimental gene therapy for Huntington's disease failed to meet its primary goal in a clinical trial, raising concerns about future revenue for ClearPoint's delivery technology.

Webull to Launch No-Code AI Tool for Trade Preparation via Claude, Perplexity
The online brokerage is expanding its cloud-based AI integration, allowing eligible U.S. users to research markets and prepare trades using natural language on platforms like Claude and Perplexity, without any software installation.

Iovance Biotherapeutics Raises Revenue Forecast on Strong Amtagvi Demand, Shares Surge
The biotech company boosted its full-year 2026 revenue guidance by approximately 15% at the midpoint, citing accelerating demand for its cancer therapies Amtagvi and Proleukin.

J.P. Morgan Upgrades Bureau Veritas to Overweight on Growth and M&A Outlook
J.P. Morgan raised its rating on the inspection and certification firm to “Overweight,” citing an expected recovery in organic growth driven by data centers and an increased capacity for acquisitions.